2017
DOI: 10.17576/jsm-2017-4608-14
|View full text |Cite
|
Sign up to set email alerts
|

New Chemical Constituent from the Rhizomes of Johannesteijsmannia altifrons

Abstract: A new compound namely 2-[(1′E)-3′-hydroxyl-1′-methyl-1′-propen-1′-yl]-6-methoxy-7-[(2′′-methylheptyl)oxy]-5benzofurancarboxylic acid and three known compounds of β-sitosterol, γ-taraxasterol and stigmasterol were isolated from the n-hexane extracts of the rhizomes and fruits of Johannesteijsmannia altifrons using vacuum liquid, column and radial chromatography. The structures of the isolated compounds were determined by means of 1D and 2D NMR, FT-IR, UV-VIS spectroscopy and mass spectrometry.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 4 publications
(3 reference statements)
0
1
0
Order By: Relevance
“…Most Trachycarpeae plants are characterized by the prevalence of lipoids (triterpenoids and steroids), polyphenols (flavonoids and phenolic acids), and saponins, as major bioactive secondary metabolites [ 12 , 13 , 14 ]. Moreover, several scientifically-based bioactivities are ascribed to members of this tribe including anti-inflammatory, antioxidant, antiprotozoal, antidiabetic, anti-hyperlipidemic, antimicrobial, antiviral, anti-benign prostate hyperplasia, and anti-prostatic cancer [ 14 , 15 , 16 , 17 ].…”
Section: Introductionmentioning
confidence: 99%
“…Most Trachycarpeae plants are characterized by the prevalence of lipoids (triterpenoids and steroids), polyphenols (flavonoids and phenolic acids), and saponins, as major bioactive secondary metabolites [ 12 , 13 , 14 ]. Moreover, several scientifically-based bioactivities are ascribed to members of this tribe including anti-inflammatory, antioxidant, antiprotozoal, antidiabetic, anti-hyperlipidemic, antimicrobial, antiviral, anti-benign prostate hyperplasia, and anti-prostatic cancer [ 14 , 15 , 16 , 17 ].…”
Section: Introductionmentioning
confidence: 99%